Improving estimates of children living with HIV from the Spectrum AIDS Impact Model

AIDS

Volumn 31, Issue , 2017, Pages S13-S22

  Mahy, Mary ^a   Penazzato, Martina ^b   Ciaranello, Andrea ^c   Mofenson, Lynne ^d   Yianoutsos, Constantin T ^e   Davies, Mary Ann ^f   Stover, John ^f  

^a UNAIDS   (Switzerland)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION   (United States)

^d INDIANA UNIVERSITY   (United States)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

^f AVENIR HEALTH   (United States)

Author keywords

antiretroviral therapy; models; mother to child transmission; paediatric HIV; seroprevalence

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; COTRIMOXAZOLE; NEVIRAPINE; ZIDOVUDINE;

ADOLESCENT; AGE DISTRIBUTION; ANTIRETROVIRAL THERAPY; CD4 LYMPHOCYTE COUNT; CHILD; COMBINATION DRUG THERAPY; DISEASE COURSE; DYING; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCIDENCE; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; MORTALITY RATE; NEWBORN; PRE-EXPOSURE PROPHYLAXIS; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; REVIEW; SOFTWARE; SURVIVAL ANALYSIS; SURVIVAL RATE; VALIDATION STUDY; VERTICAL TRANSMISSION; VIRUS TRANSMISSION; EPIDEMIOLOGICAL MONITORING; PRESCHOOL CHILD; PREVALENCE; STATISTICAL MODEL; TRANSMISSION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGICAL MONITORING; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; MODELS, STATISTICAL; PREVALENCE; SOFTWARE;

EID: 84992316922     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000001306     Document Type: Review

References (27)

1. UNAIDS. The Prevention Gap Report. Geneva, Switzerland; 2016. http://www.unaids.org/en/resources/documents/2016/prevention-gap. [Accessed 5 August 2016]
2. World Health Organization. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. (second edition). Geneva, Switzerland; 2016. http://www.who.int/hiv/pub/arv/arv-2016/en/. [Accessed 5 August 2016]
3. Penazzato M, Bendaud V, Nelson L, Stover J, Mahy M. Estimating future trends in paediatric HIV. AIDS 2014; 28 (Suppl 4): S445-S451.
4. Schwärtlander B, Stanecki KA, Brown T, Way PO, Monasch R, Chin J,, et al. Country-specific estimates and models of HIV and AIDS: methods and limitations. AIDS 1999; 13: 2445-2458.
5. UNAIDS, World Health Organization, UNICEF. Consultative meeting on Data Collection and Estimation Methods Related to HIV Infection in Infants and Children. New York: UNICEF; 2008. http://www.epidem.org/Publications/UNAIDS-UNI CEF-Paediatric%20HIV%20Report-9%20Dec%202008-Final.pdf. [Accessed 18 March 2010].
6. UNAIDS Reference Group on Estimates Modelling and Projections. Paediatric estimation issues with a focus on ART need estimates. London, UK: Imperial College; 2009. http://www. epidem.org/paediatric-estimation-issues-with-A-focus-on-Artneed-estimates-0. [Accessed 19 August 2016].
7. UNAIDS Reference Group on Estimates Modelling and Projections. Updating Estimates of Mother-To-Child Transmission Rates of HIV; 2010. http://www.epidem.org/sites/default/files/reports/MTCT-Washington-Meeting%20Report-24Jan2011-FINAL.pdf. [Accessed 19 August 2016].
8. UNAIDS Reference Group on HIV Estimates Modeling and Projections. Modelling Paediatric HIV and the Need for Antiretroviral Therapy: Report and recommendations from a meeting of theWHOand UNAIDS in collaboration with the UNAIDS Reference Group on Estimates, Modelling and Projections, London, UK, 28-29 October 2015; 2015. http://www.epidem. org/sites/default/files/reports/Paeds-Report-Oct%202015.pdf. [Accessed 16 August 2016].
9. Stover J, Andreev K, Slaymaker E, Gopalappa C, Sabin K, Velasquez C,, et al. Updates to the spectrum model to estimate key HIV indicators for adults and children. AIDS 2014; 28 (Suppl 4): S427-434.
10. Chen W-J, Walker N. Fertility of HIV-infected women: insights from demographic and health surveys. Sex Trans Infect 2010; 86: ii22-ii27.
11. Rollins N, Mahy M, Becquet R, Kuhn L, Creek T, Mofenson L. Estimates of peripartum and postnatal mother-To-child transmission probabilities of HIV for use in Spectrum and other population-based models. Sex Transm Infect 2012; 88 (Suppl 2): i44-51.
12. Rollins N, Little K, Mzolo S, Horwood C, Newell ML. Surveillance of mother-To-child transmission prevention programmes at immunization clinics: the case for universal screening. AIDS 2007; 21: 1341-1347.
13. Stover J, Brown T, Marston M. Updates to the Spectrum/Estimation and Projection Package (EPP) model to estimate HIV trends for adults and children. Sex Transm Infect 2012; 88 (Suppl 2): i11-i16.
14. Becquet R, Marston M, Dabis F, Moulton LH, Gray G, Coovadia HM,, et al. Children who acquire HIV infection perinatally are at higher risk of early death than those acquiring infection through breastmilk: a meta-Analysis. PLoS One 2012; 7: e28510.
15. Dunn D, Woodburn P, Duong T, Peto J, Phillips A, Gibb D,, et al. Current CD4 cell count and the short-Term risk of AIDS and death before the availability of effective antiretroviral therapy in HIV-infected children and adults. J Infect Dis 2008; 197: 398-404.
16. Marston M, Becquet R, Zaba B, Moulton LH, Gray G, Coovadia H,, et al. Net survival of perinatally and postnatally HIVinfected children: a pooled analysis of individual data from sub-Saharan Africa. Int J Epidemiol 2011; 40: 385-396.
17. Koller M, Patel K, Chi BH, Wools-Kaloustian K, Dicko F, Chokephaibulkit K,, et al. Immunodeficiency in children starting antiretroviral therapy in low-, middle-, and high-income countries. J Acquir Immune Defic Syndr 2015; 68: 62-72.
18. A survey of paediatric HIV programmatic and clinical management practices in Asia and sub-Saharan Africa: the International epidemiologic Databases to Evaluate AIDS (IeDEA). J Int AIDS Soc 2013; 16: 17998.
19. Leroy V, Malateste K, Rabie H, Lumbiganon P, Ayaya S, Dicko F,, et al. Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration. J Acquir Immune Defic Syndr 2013; 62: 208-219.
20. Ekouevi DK, Azondekon A, Dicko F, Malateste K, Toure P, Eboua FT,, et al. 12-month mortality and loss-To-program in antiretroviral-Treated children: the IeDEA pediatric West African Database to evaluate AIDS (pWADA), 2000-2008. BMC Public Health 2011; 11: 519.
21. Sinunu MA, Schouten EJ, Wadonda-Kabondo N, Kajawo E, Eliya M, Moyo K,, et al. Evaluating the impact of prevention of mother-To-child transmission of HIV in Malawi through immunization clinic-based surveillance. PLoS One 2014; 9: e100741.
22. Goga AE, Dinh TH, Jackson DJ, Lombard C, Delaney KP, Puren A,, et al. First population-level effectiveness evaluation of a national programme to prevent HIV transmission from mother to child, South Africa. J Epidemiol Commun Health 2015; 69: 240-248.
23. Buzdugan R, Kang Dufour MS, McCoy SI, Watadzaushe C, Dirawo J, Mushavi A,, et al. Option A improved HIV-free infant survival and mother to child HIV transmission at 9-18 months in Zimbabwe. AIDS 2016; 30: 1655-1662.
24. Zimbabwe National Statistics Agency and ICF International. Zimbabwe Demographic and Health Survey 2015: Key Indicators. Rockville, Maryland, USA Zimbabwe National Statistics Agency (ZIMSTAT) and ICF International; 2016. http://dhsprogram. com/pubs/pdf/PR72/PR72.pdf. [Accessed 19 August 2016].
25. Silohol R, Gregson S, Nyamukapa C, Mhangara M, Dzangare J, Gonese E,, et al. Empirical validation of the UNAIDS Spectrum model for subnational HIV estimates: case-study of children and adults in Manicaland, Zimbabwe. AIDS 2017; 31 (Suppl 1): S41-S50.
26. Marston M, Nakiyingi-Miiro J, Kusemererwa S, Urassa M, Michael D, Nyamukapa C,, et al. The effects of HIV on fertility by infection duration: evidence from African population cohorts before antiretroviral treatment availability. AIDS 2017; 31 (Suppl 1): S69-S76.
27. World Health Organization. Measuring the Impact of National PMTCT Programmes. Geneva, Switzerland: World Health Organization; 2012. http://apps.who.int/iris/bitstream/10665/75478/1/9789241504362-eng.pdf?ua=1. Accessed 19 August 2016.